(Q38028378)

27 August 2017

title

Nitric oxide in myogenesis and therapeutic muscle repair (English)

1 reference

27 August 2017

Clara De Palma

1

0 references

Emilio Clementi

series ordinal

2

object named as

Emilio Clementi

1 reference

27 August 2017

publication date

22 July 2012

1 reference

27 August 2017

published in

Molecular Neurobiology

1 reference

27 August 2017

volume

46

1 reference

27 August 2017

issue

3

1 reference

27 August 2017

page(s)

682-692

1 reference

https://scigraph.springernature.com/pub.10.1007/s12035-012-8311-8

27 August 2017

exact match

0 references

cites work

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Nitric oxide synthases: structure, function and inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Involvement of nitric oxide system in experimental muscle crush injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Cell death and oxidative damage in inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding/inhibitory domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

PIN: an associated protein inhibitor of neuronal nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Kalirin inhibition of inducible nitric-oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Localization of endothelial nitric-oxide synthase phosphorylated on serine 1179 and nitric oxide in Golgi and plasma membrane defines the existence of two pools of active enzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Caveolin-1 down-regulates inducible nitric oxide synthase via the proteasome pathway in human colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Interactions between nitric oxide and sphingolipids and the potential consequences in physiology and pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

On the mechanism by which vascular endothelial cells regulate their oxygen consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Nitric oxide and mitochondrial biogenesis: a key to long-term regulation of cellular metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Mitochondrial type I nitric oxide synthase physically interacts with cytochrome c oxidase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Nitric oxide, cytochrome C oxidase, and the cellular response to hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Does nitric oxide modulate mitochondrial energy generation and apoptosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Postnatal development and plasticity of specialized muscle fiber characteristics in the hindlimb

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Fas-induced caspase denitrosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

S-Nitrosylation of mitochondrial caspases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Biological chemistry of reactive oxygen and nitrogen and radiation-induced signal transduction mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Nitric oxide represses inhibitory kappaB kinase through S-nitrosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Nitric oxide-mediated inhibition of Hdm2-p53 binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Nitric oxide deficiency determines global chromatin changes in Duchenne muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Nonmyogenic cells in skeletal muscle regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Niche regulation of muscle satellite cell self-renewal and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Myogenic progenitor cells in the mouse embryo are marked by the expression of Pax3/7 genes that regulate their survival and myogenic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Molecular signature of quiescent satellite cells in adult skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

All muscle satellite cells are equal, but are some more equal than others?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

The skeletal muscle satellite cell: the stem cell that came in from the cold.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Skeletal muscle progenitor cells and the role of Pax genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Anabolic potential and regulation of the skeletal muscle satellite cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Pax7 and myogenic progression in skeletal muscle satellite cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Wnt7a activates the planar cell polarity pathway to drive the symmetric expansion of satellite stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

A temporal switch from notch to Wnt signaling in muscle stem cells is necessary for normal adult myogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Requirement of cell cycle and apoptosis regulator 1 for target gene activation by Wnt and beta-catenin and for anchorage-independent growth of human colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Canonical Wnt signalling induces satellite-cell proliferation during adult skeletal muscle regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

BCL9 is an essential component of canonical Wnt signaling that mediates the differentiation of myogenic progenitors during muscle regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Nitric oxide sustains long-term skeletal muscle regeneration by regulating fate of satellite cells via signaling pathways requiring Vangl2 and cyclic GMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Regulation of vascular smooth muscle cell phenotype by cyclic GMP and cyclic GMP-dependent protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Role of cyclic GMP in gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Nitric oxide effects on cell growth: GMP-dependent stimulation of the AP-1 transcription complex and cyclic GMP-independent slowing of cell cycling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Wnt signaling and the activation of myogenesis in mammals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

A role for nitric oxide in muscle repair: nitric oxide-mediated activation of muscle satellite cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Nitric oxide regulates the repair of injured skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Signaling satellite-cell activation in skeletal muscle: markers, models, stretch, and potential alternate pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Nitric oxide inhibition of Drp1-mediated mitochondrial fission is critical for myogenic differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Nitric oxide, cell bioenergetics and neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Defective regulation of energy metabolism in mdx-mouse skeletal muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Mitochondrial dysfunction and neuromuscular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Impaired mitochondrial oxidative phosphorylation in skeletal muscle of the dystrophin-deficient mdx mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Follistatin induction by nitric oxide through cyclic GMP: a tightly regulated signaling pathway that controls myoblast fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

The expression of endothelial nitric-oxide synthase is controlled by a cell-specific histone code.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Role of histone deacetylation in cell-specific expression of endothelial nitric-oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

iNOS ablation does not improve specific force of the extensor digitorum longus muscle in dystrophin-deficient mdx4cv mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Loss of sarcolemma nNOS in sarcoglycan-deficient muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Loss of sarcolemmal nNOS is common in acquired and inherited neuromuscular disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Functional deficits in nNOSmu-deficient skeletal muscle: myopathy in nNOS knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

NO skeletal muscle derived relaxing factor in Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Sarcolemma-localized nNOS is required to maintain activity after mild exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Prednisone for Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Current status of pharmaceutical and genetic therapeutic approaches to treat DMD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Systemic administration of PRO051 in Duchenne's muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Restoration of the dystrophin-associated glycoprotein complex after exon skipping therapy in Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Neuronal nitric oxide synthase-rescue of dystrophin/utrophin double knockout mice does not require nNOS localization to the cell membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

L-arginine improves dystrophic phenotype in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Development of a nitric oxide-releasing analogue of the muscle relaxant guaifenesin for skeletal muscle satellite cell myogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Systemic administration of L-arginine benefits mdx skeletal muscle function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

L-arginine decreases inflammation and modulates the nuclear factor-kappaB/matrix metalloproteinase cascade in mdx muscle fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

MALDI reveals membrane lipid profile reversion in MDX mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Muscle regeneration in dystrophic mdx mice is enhanced by isosorbide dinitrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Dietary nitrate supplementation enhances muscle contractile efficiency during knee-extensor exercise in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Dietary inorganic nitrate improves mitochondrial efficiency in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Cyclooxygenase-inhibiting nitric oxide donators for osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

A dual acting compound releasing nitric oxide (NO) and ibuprofen, NCX 320, shows significant therapeutic effects in a mouse model of muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Gene therapy with the angiogenic cytokine secretoneurin induces therapeutic angiogenesis by a nitric oxide-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

beta-Catenin promotes self-renewal of skeletal-muscle satellite cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

Nitric oxide moves myoglobin centre stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

The role of nitric oxide during healing of trauma to the skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8311-8

On the mechanism of NO release from sydnonimines

21 January 2018

1 reference

12 December 2020

Ex vivo treatment with nitric oxide increases mesoangioblast therapeutic efficacy in muscular dystrophy

1 reference

12 December 2020

Exercise-stimulated glucose transport in skeletal muscle is nitric oxide dependent

1 reference

12 December 2020

1 reference

12 December 2020

MicroRNAs Involved in Molecular Circuitries Relevant for the Duchenne Muscular Dystrophy Pathogenesis Are Controlled by the Dystrophin/nNOS Pathway

1 reference

12 December 2020

Nitric oxide donor and non steroidal anti inflammatory drugs as a therapy for muscular dystrophies: Evidence from a safety study with pilot efficacy measures in adult dystrophic patients

1 reference

12 December 2020

Physiology of nitric oxide in skeletal muscle

1 reference

12 December 2020

Role of nitric oxide and its intracellular signalling pathways in the control of Ca2+ homeostasis

1 reference

12 December 2020

Three-dimensional electron microscopy of mitochondria and endoplasmic reticulum in the red muscle fiber of the rat diaphragm

1 reference

12 December 2020

Neuronal NOS is dislocated during muscle atrophy in amyotrophic lateral sclerosis

1 reference

12 December 2020

Beta catenin-independent activation of MyoD in presomitic mesoderm requires PKC and depends on Pax3 transcriptional activity

1 reference

12 December 2020

Nitric oxide as a messenger molecule for myoblast fusion.

1 reference

12 December 2020

Expression of nitric oxide synthase in skeletal muscle: a novel role for nitric oxide as a modulator of insulin action

1 reference

12 December 2020

Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough?

1 reference

12 December 2020

Biochemical characterization of S-nitrosohemoglobin. Mechanisms underlying synthesis, no release, and biological activity

1 reference

12 December 2020

Early functional muscle regeneration after myotoxic injury in mice is unaffected by nNOS absence

1 reference

12 December 2020

Functional and molecular adaptations in skeletal muscle of myoglobin-mutant mice

1 reference

12 December 2020

Muscle cells from mdx mice have an increased susceptibility to oxidative stress

1 reference

12 December 2020

Nitric oxide: physiology, pathophysiology, and pharmacology

1 reference

12 December 2020

Protein interactions with nitric oxide synthases: controlling the right time, the right place, and the right amount of nitric oxide

1 reference

12 December 2020

Nitric oxide, a biological double-faced janus--is this good or bad?

1 reference

12 December 2020

Evidence that nitric oxide increases glucose transport in skeletal muscle

1 reference

12 December 2020

Adult stem cell specification by Wnt signaling in muscle regeneration

1 reference

12 December 2020

Persistent and improved functional gain in mdx dystrophic mice after treatment with L-arginine and deflazacort

1 reference

12 December 2020

10.1007/S12035-012-8311-8

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1004169576

0 references

1 reference